HR NEWS

Arthritis drug may be new hope for skin cancer

Arthritis drug may be new hope for skin cancer

Combining the treatment for the most deadly form of skin cancer with a common anti-rheumatic drug could provide more effective results, new research has shown. The findings showed that using “leflunomide” — an immunosuppressive drug approved for treatment of rheumatoid arthritis — in combination with another melanoma drug, selumetinib almost completely stopped the growth of a melanoma tumour in mice. “By combining therapies, it’s possible to attack the disease from several angles, which makes it harder for the melanoma to develop resistance to any of the drugs,” said Grant Wheeler from the University of East Anglia (UEA) in the UK. “Our research has shown that there could also be further benefits – by joining these two drugs together you may be able to enhance their effects, getting a treatment that is more than the sum of its parts,” Wheeler said.

Although only five per cent of skin cancer cases involve melanoma, it causes the majority of deaths from the disease. If caught early, melanoma is very treatable, but once the cancer has metastasised or spread, then treatment becomes more difficult. The research, published in the journal Oncotarget, tested leflunomide’s effect against melanoma with selumetinib. When the team tested leflunomide in the lab, it was found to work on melanoma cells irrespective of the genetic signature of the cancer. This means that leflunomide has the potential to be used in all melanoma cases, not just for tumours harbouring BRAF mutations, the researchers said.

However, when leflunomide was tested on melanoma cells jointly with selumetinib, the scientists found it was more effective than either drug on its own. In mice, the two drugs together almost completely halted the growth of the tumour over a 12 day period, which far outstripped the effect of either drug used in isolation, the researchers said.

10 months ago

By HR Reporters

Related Tags :   • Health News

Social Share : Share      

Comments.....

Submit new comment

Most Viewed

AK Chaudhary to take over as SAIL chief...

8 months ago

World’s 500 richest people have lost combined 107 billion USD this week...

8 months ago

South East Central Railway Recruitment 2018: Applications invited for 329 posts ...

2 months ago

More baby girls than boys die in India, says UNICEF report...

8 months ago

"Gulf 23" kicks off with superb inaugural ceremony ...

10 months ago

Argos drivers’ strike over holiday pay and overtime called off - UK HR News...

2 years ago

Microsoft co-founder Bill Gates hails India’s expertise in public health but cal...

5 months ago

Intel appoints Prakash Mallya as MD, South Asia...

2 years ago

24 unbelievable excuses employees have given for skipping work...

2 years ago

Poor dental health ups frailty risk in older men, says study...

10 months ago

Most Shared

Mass redundancies for Quebec cookie factory...

2 years ago

Trump this: 5 bold predictions for how he’ll impact HR...

2 years ago

InfoTycoon appoints existing President and COO Kevin George to succeed James Dav...

2 years ago

Sushant Dwivedy joins Aspiring Minds as SVP-Enterprise Client Solutions...

2 years ago

Uber introduces special reward programme...

2 years ago

Standard Chartered Bank to reduce 10% corporate & institutional banking staff...

2 years ago

National CineMedia (NCM) creates Affiliate Partnerships team, names Stacie Tursi...

2 years ago

OCC Names New CFO, Treasurer, and Chief Compliance Officer...

2 years ago

Beards at work are now a major turn-off say 61% of female office workers...

2 years ago

First female fast jet pilot of Britain hired as director at PwC...

2 years ago